Molecular tests and target therapies in oncology: recommendations from the Italian workshop

Precision medicine in 2030—seven ways to transform healthcare

(2021) Joshua C. Denny et al.   CELL

THE MOLECULAR ANALYSIS FOR THERAPY CHOICE (NCI-MATCH) TRIAL: LESSONS for GENOMIC TRIAL DESIGN

(2020) Keith T Flaherty et al.   JNCI-Journal of the National Cancer Institute

Molecular profiling for precision cancer therapies

(2020) Eoghan R. Malone et al.   Genome Medicine

The National Lung Matrix Trial of personalized therapy in lung cancer

(2020) Gary Middleton et al.   NATURE

A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system

(2020) Silvia Riva et al.   SUPPORTIVE CARE IN CANCER

Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol

(2019) Silvia Riva et al.   BMJ Open

Genome Sequencing during a Patient’s Journey through Cancer

(2019) Jyoti Nangalia et al.   NEW ENGLAND JOURNAL OF MEDICINE

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

(2018) J Mateo et al.   ANNALS OF ONCOLOGY

The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy

(2016) F. Perrone et al.   ANNALS OF ONCOLOGY

Building a Personalized Medicine Infrastructure at a Major Cancer Center

(2013) Funda Meric-Bernstam et al.   JOURNAL OF CLINICAL ONCOLOGY

Genomics-Driven Oncology: Framework for an Emerging Paradigm

(2013) Levi A. Garraway   JOURNAL OF CLINICAL ONCOLOGY

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

(2013) Garrett M Frampton et al.   NATURE BIOTECHNOLOGY